In vitro antiviral activity of dehydroepiandrosterone and its synthetic derivatives against vesicular stomatitis virus

Veterinary Journal

Volumn 182, Issue 2, 2009, Pages 327-335

  Romanutti, Carina ^a   Bruttomesso, Andrea C ^a   Castilla, Viviana ^a   Bisceglia, Juan A ^a   Galagovsky, Lydia R ^a   Wachsman, Mónica B ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antiviral; Dehydroepiandrosterone analogs; DHEA; EA; Vesicular stomatitis virus

Indexed keywords

1 BETA DEXTRO RIBOFURANOSIL 1 2 4 TRIAZOLE 3 CARBOXAMIDE; 16ALPHA HYDROXYPRASTERONE; 17 OXO 5ALPHA ANDROSTAN 3BETA,16ALPHA YLDIACETATE; 17 OXO 5ALPHA ANDROSTAN 3BETA,16BETA YLDIACETATE; 17 OXOANDROST 5 EN 3BETA YL ACETATE; 17 OXOANDROST 5 EN 3BETA YLACETAE; 17 OXOANDROST 5 EN 3BETA,16ALPHA DIYLDIACETATE; 17 OXOANDROST 5 EN 3BETA,16BETA YLDIACETATE; 17,17 ETHYLENDIOXY 3BETA ANDROSTANYL ACETATE; 17,17 ETHYLENDIOXYANDROST 5 EN 3BETA OL; 17,17 ETHYLENDIOXYANDROST 5,15 DIEN 3BETA OL; 17,17 ETHYLENDIOXYANDROSTAN 16ALPHA BROMO 3BETA OL; 17,17 ETHYLENDIOXYANDROSTAN 3BETA OL; 17,17 ETHYLENDIOXYANDROSTAN 5,15 DIEN 3BETA OL; 21 NORPREGNA 5,17(20) DIEN 3BETA,16ALPHA DIYLDIACETATE; 3BETA 6ALPHA DIHYDROXY 17 ANDROSTANONE; 3BETA HYDROXYPREGN 17(20) EN 16 ONE; 3BETA,15ALPHA DIHYDROXY 5ALPHA ANDROSTAN 17 ONE; 3BETA,15BETA DIHYDROXY 5ALPHA ANDROSTAN 17 ONE; 3BETA,16ALPHA DIHYDROXY 5ALPHA ANDROSTAN 17 ONE; ANDROSTA 5,16 DIEN 3BETA,17 DIYLDIACETATE; ANTIVIRUS AGENT; EPIANDROSTERONE; PRASTERONE; PRASTERONE DERIVATIVE; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PROTEIN SYNTHESIS; RNA SYNTHESIS; VERO CELL; VESICULAR STOMATITIS VIRUS; VIROGENESIS; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DEHYDROEPIANDROSTERONE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VERO CELLS; VESICULAR STOMATITIS; VESICULOVIRUS; VIRUS REPLICATION;

VESICULAR STOMATITIS VIRUS;

EID: 69949111854     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.06.015     Document Type: Article

References (30)

1. Barr J.N., Whelan S.P.J., and Wertz G.W. Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus. Biochimica et Biophysica Acta 1577 (2002) 337-353
2. Bradley W., Kraus L., Good R., and Day N. Dehydroepiandrosterone inhibits replication of feline immunodeficiency virus in chronically infected cells. Veterinary Immunology and Immunopathology 46 (1995) 159-168
3. Bruttomesso A.C., Gros E.G., Ponce M.A., and Balsells R.E. Photooxygenation of pregnanes. Helvetic Chimica Acta 87 (2004) 2987-3003
4. Cantlon J.D., Gordy P.W., and Bowen R.A. Immune responses in mice, cattle and horses to a DNA vaccine for vesicular stomatitis. Vaccine 18 (2000) 2368-2374
5. Chang C.C., Ou Y.C., Rang S.L., and Chen C.J. Antiviral effect of dehydroepiandrosterone on Japanese Encephalitis virus infection. Journal of General Virology 86 (2005) 2513-2523
6. Defaye G., and Chambaz E.M. Synthesis of 15β-hydroxylated derivatives of dehydroisoandrosterone and isoandrosterone. Tetrahedron Letters 19 (1978) 3849-3850
7. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Journal of Immunological Methods 89 (1986) 271-277
8. Diallo K., Loemba H., Oliveira M., Mavoungou D.D., and Wainberg M.A. Inhibition of human immunodeficiency virus type-1 (HIV-1) replication by immunor (IM28), a new analog of dehydroepiandrosterone. Nucleosides Nucleotides Nucleic Acids 19 (2000) 2019-2024
9. Flanagan E.B., Zamparo J.M., Ball L.A., Rodriguez L.L., and Wertz G.W. Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development. Journal of Virology 75 (2001) 6107-6114
10. Graci J.D., and Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Reviews in Medical Virology 16 (2006) 37-48
11. Henderson E., Yang J., and Schwartz A. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replication. AIDS Research and Human Retroviruses 8 (1992) 625-631
12. Iwasaki M. The Reformatsky reaction of 17-ketosteroids with ethyl α-bromopropionate. Steroids 9 (1967) 373-386
13. Johnson W.S., Gastambide B., and Pappo R. The action of lead tetra-acetate on an enol acetate. Their interconversion and rearrangement. Journal of the American Chemical Society 79 (1957) 1991-1994
14. Leeds N.S., Fukushima D.K., and Gallagher T.F. Studies of steroid ring D epoxides of enol acetates; a new synthesis of estriol and of androstane-3β,16α,17β-triol. Journal of the American Chemical Society 76 (1954) 2943-2948
15. Letchworth G.J., Rodriguez L.L., and Barrera J.D.C. Vesicular stomatitis. The Veterinary Journal 157 (1999) 239-260
16. Loria R.M., Inge T.H., Cook S.S., Szakal A.K., and Regelson W. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). Journal of Medical Virology 26 (1988) 301-314
17. Loria R.M., and Padgett D.A. Androstenediol regulates systemic resistance against lethal infections in mice. Archives of Virology 127 (1992) 103-115
18. Mavoungou D., Poaty-Mavoungou V., Akoume M., Ongali B., and Mavoungou E. Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell- cell fusion by immunor (IM28). Virology Journal 11 (2005) 9-10
19. McElroy M.C., and Basset H.F. The development of oral lesions in lambs naturally infected with orf virus. The Veterinary Journal 174 (2007) 673-674
20. Numazawa M., and Osawa Y. Improved synthesis of 16 alpha-hydroxylated androgens: intermediates of estriol formation in pregnancy. Steroids 32 (1978) 519-527
21. Numazawa M., and Nagaoka M. Stereospecific synthesis of 16α-hydroxy-17-oxo steroids by controlled alkaline hydrolysis of corresponding 16-bromo-17-ketones and its reaction mechanism. Journal of Organic Chemistry 47 (1982) 4024-4029
22. Padgett D.A., Loria R.M., and Sheridan J.F. Steroid hormone regulation of antiviral immunity. Journal of Neuroimmunology 78 (1997) 203-311
23. Pedersen N.C., North T.W., Rigg R., Reading C., Higgins J., Leutenegger C., and Henderson G.L. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression. Veterinary Immunology and Immunopathology 94 (2003) 133-148
24. Rodriguez L.L. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Research 85 (2002) 211-219
25. Romanutti C., Castilla V., Coto C.E., and Wachsman M.B. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells. International Journal of Antimicrobial Agents 29 (2007) 311-316
26. Rose J.K., and Whitt M.A. Rhabdoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fundamental Virology 4 (2001), Lippincott Williams & Wilkins, Philadelphia, USA 665-688
27. Sondheimer F., Burstein S., and Mechoulam R. Syntheses in the cardiac aglycone field III. The conversion of a 14α- to a 14β- hydroxy group in the androstane series. The ultraviolet spectra of ρ15-androstene-17-ones. Journal of the American Chemical Society 82 (1960) 3209-3212
28. Wachsman M.B., López E.M.F., Ramírez J.A., Galagovsky L.R., and Coto C.E. Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antiviral Chemistry and Chemotherapy 11 (2000) 71-77
29. Wachsman M.B., Ramírez J.A., Talarico L.B., Galagovsky L.R., and Coto C.E. Antiviral activity of natural and synthetic brassinosteroids. Current Medicinal Chemistry - Anti-Infective Agents 3 (2004) 163-179
30. Yoneda M., Wada K., Katayama K., Nakajima N., Blumberg R., and Nakajima A. A novel therapy for acute hepatitis utilizing dehydroepiandrosterone in the murine model of hepatitis. Biochemistry and Pharmacology 68 (2004) 2283-2289